{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T18:41:07Z","timestamp":1789929667056,"version":"4.0.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2006,8,1]],"date-time":"2006-08-01T00:00:00Z","timestamp":1154390400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Can J Anesth"],"published-print":{"date-parts":[[2006,8]]},"DOI":"10.1007\/bf03022797","type":"journal-article","created":{"date-parts":[[2009,5,3]],"date-time":"2009-05-03T20:28:37Z","timestamp":1241382517000},"page":"802-809","source":"Crossref","is-referenced-by-count":48,"title":["Determinants of complications with recombinant factor VIIa for refractory blood loss in cardiac surgery","Les d\u00e9terminants de complications avec le facteur VIIa recombinant utilis\u00e9 pour les pertes sanguines r\u00e9fractaires en chirurgie cardiaque"],"prefix":"10.1007","volume":"53","author":[{"given":"Keyvan","family":"Karkouti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terrence M.","family":"Yau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheila","family":"Riazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen M.","family":"Dattilo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcin","family":"Wasowicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimiliano","family":"Meineri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart A.","family":"McCluskey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duminda N.","family":"Wijeysundera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriaan","family":"van Rensburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. Scott","family":"Beattie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BF03022797_CR1","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S1473-0502(02)00029-0","volume":"27","author":"WN Erber","year":"2002","unstructured":"Erber WN. Massive blood transfusion in the elective surgical setting. Transfus Apher Sci 2002; 27:83\u201392.","journal-title":"Transfus Apher Sci"},{"key":"BF03022797_CR2","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.0042-9007.2004.00393.x","volume":"86","author":"AD Clark","year":"2004","unstructured":"Clark AD, Gordon WC, Walker ID, Tait RC. \u2018Last- ditch\u2019 use of recombinant factor VIIa in patients with massive haemorrhage is ineffective. Vox Sang 2004; 86:120\u20134.","journal-title":"Vox Sang"},{"key":"BF03022797_CR3","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/j.1445-5994.2005.00878.x","volume":"35","author":"B Loudon","year":"2005","unstructured":"Loudon B, Smith MP. Recombinant factor VIIa as an adjunctive therapy for patients requiring large volume transfusion: a pharmacoeconomic evaluation. Intern Med J 2005; 35:463\u20137.","journal-title":"Intern Med J"},{"key":"BF03022797_CR4","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1537-2995.2005.04216.x","volume":"45","author":"K Karkouti","year":"2005","unstructured":"Karkouti K, Beattie WS, Wijeysundera DN, et al. Recombinant factor VIIa for intractable blood loss after cardiac surgery: a propensity score-matched case- control analysis. Transfusion 2005; 45:26\u201334.","journal-title":"Transfusion"},{"key":"BF03022797_CR5","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.athoracsur.2005.04.007","volume":"80","author":"G Despotis","year":"2005","unstructured":"Despotis G, Avidan M, Lublin DM. Off-label use of recombinant factor VIIa concentrates after cardiac surgery. Ann Thorac Surg 2005; 80:3\u20135.","journal-title":"Ann Thorac Surg"},{"key":"BF03022797_CR6","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/S0022-5223(97)70373-8","volume":"113","author":"M Ernofsson","year":"1997","unstructured":"Ernofsson M, Thelin S, Siegbahn A. Monocyte tissue factor expression, cell activation, and thrombin formation during cardiopulmonary bypass: a clinical study. J Thorac Cardiovasc Surg 1997; 113:576\u201384.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"BF03022797_CR7","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1161\/01.CIR.93.11.2014","volume":"93","author":"JH Chung","year":"1996","unstructured":"Chung JH, Gikakis N, Rao AK, Drake TA, Colman RW, Edmunds LH Jr. Pericardial blood activates the extrinsic coagulation pathway during clinical cardiopulmonary bypass. Circulation 1996; 93:2014\u20138.","journal-title":"Circulation"},{"issue":"Suppl 1","key":"BF03022797_CR8","first-page":"S61","volume":"9","author":"M Hoffman","year":"1998","unstructured":"Hoffman M, Monroe DM III, Roberts HR. Activated factor VII activates factors IX and X on the surface of the activated platelets: thoughts on the mechanism of action of high-dose activated factor VII. Blood Coagul Fibrinolysis 1998; 9(Suppl 1):S61\u20135.","journal-title":"Blood Coagul Fibrinolysis"},{"key":"BF03022797_CR9","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1097\/00000539-200205000-00070","volume":"94","author":"W Dietrich","year":"2002","unstructured":"Dietrich W, Spannagl M. Caveat against the use of activated recombinant factor VII for intractable bleeding in cardiac surgery (Letter). Anesth Analg 2002; 94:1369\u201370.","journal-title":"Anesth Analg"},{"key":"BF03022797_CR10","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/BF03018233","volume":"51","author":"JF Hardy","year":"2004","unstructured":"Hardy JF, de Moerloose P, Samama M;Groupe d\u2019Int\u00e9r\u00eat en H\u00e9mostase P\u00e9riop\u00e9ratoire. Massive transfusion and coagulopathy: pathophysiology and implications for clinical management. Can J Anesth 2004; 51:293\u2013310.","journal-title":"Can J Anesth"},{"key":"BF03022797_CR11","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/(SICI)1096-8652(199809)59:1<65::AID-AJH13>3.0.CO;2-0","volume":"59","author":"MJ Carey","year":"1998","unstructured":"Carey MJ, Rodgers GM. Disseminated intravascular coagulation: clinical and laboratory aspects. Am J Hematol 1998; 59:65\u201373.","journal-title":"Am J Hematol"},{"key":"BF03022797_CR12","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1046\/j.0041-1132.2003.00577.x","volume":"43","author":"NM O\u2019Connell","year":"2003","unstructured":"O\u2019Connell NM, Perry DJ, Hodgson AJ, O\u2019Shaughnessy DF, Laffan MA, Smith OP. Recombinant FVIIa in the management of uncontrolled hemorrhage. Transfusion 2003; 43:1711\u20136.","journal-title":"Transfusion"},{"key":"BF03022797_CR13","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1128\/CDLI.10.3.495-497.2003","volume":"10","author":"E Jonge de","year":"2003","unstructured":"de Jonge E, Friederich PW, Vlasuk GP, et al. Activation of coagulation by administration of recombinant factor VIIa elicits interleukin 6 (IL-6) and IL-8 release in healthy human subjects. Clin Diagn Lab Immunol 2003; 10:495\u20137.","journal-title":"Clin Diagn Lab Immunol"},{"key":"BF03022797_CR14","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/00000542-200207000-00030","volume":"97","author":"JG Laffey","year":"2002","unstructured":"Laffey JG, Boylan JF, Cheng DC. The systemic inflammatory response to cardiac surgery. Anesthesiology 2002; 97:215\u201352.","journal-title":"Anesthesiology"},{"key":"BF03022797_CR15","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1111\/j.1537-2995.2004.04144.x","volume":"44","author":"K Karkouti","year":"2004","unstructured":"Karkouti K, Wijeysundera DN, Yau TM, et al. The independent association of massive blood loss with mortality in cardiac surgery. Transfusion 2004; 44:1453\u201362.","journal-title":"Transfusion"},{"key":"BF03022797_CR16","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/BF03022216","volume":"53","author":"K Karkouti","year":"2006","unstructured":"Karkouti K, Wijeysundera DN, Yau TM, et al. Platelet transfusions are not associated with increased morbidity or mortality in cardiac surgery. Can J Anesth 2006; 53:279\u201387.","journal-title":"Can J Anesth"},{"key":"BF03022797_CR17","doi-asserted-by":"crossref","first-page":"297","DOI":"10.2307\/j.ctt2250wks.16","volume-title":"Multivariable Analysis: An Introduction","author":"AR Feinstein","year":"1996","unstructured":"Feinstein AR. Multiple logistic regression.In: Feinstein AR (Ed.). Multivariable Analysis: An Introduction. New Haven: Yale University Press; 1996: 297\u2013330."},{"key":"BF03022797_CR18","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.ccc.2005.04.003","volume":"21","author":"R Whitlock","year":"2005","unstructured":"Whitlock R, Crowther MA, Ng HJ. Bleeding in cardiac surgery: its prevention and treatment \u2014 an evidence-based review. Crit Care Clin 2005; 21:589\u2013610.","journal-title":"Crit Care Clin"},{"key":"BF03022797_CR19","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.jtcvs.2005.02.025","volume":"130","author":"S Dial","year":"2005","unstructured":"Dial S, Delabays E, Albert M, et al. Hemodilution and surgical hemostasis contribute significantly to transfusion requirements in patients undergoing coronary artery bypass. J Thorac Cardiovasc Surg 2005; 130:654\u201361.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"BF03022797_CR20","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/S0022-5223(96)70380-X","volume":"111","author":"MJ Moulton","year":"1996","unstructured":"Moulton MJ, Creswell LL, Mackey ME, Cox JL, Rosenbloom M. Reexploration for bleeding is a risk factor for adverse outcomes after cardiac operations. J Thorac Cardiovasc Surg 1996; 111:1037\u201346.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"BF03022797_CR21","first-page":"352","volume":"7","author":"TS Hall","year":"2001","unstructured":"Hall TS, Brevetti GR, Skoultchi AJ, Sines JC, Gregory P, Spotnitz AJ. Re-exploration for hemorrhage following open heart surgery differentiation on the causes of bleeding and the impact on patient outcomes. Ann Thorac Cardiovasc Surg 2001; 7:352\u20137.","journal-title":"Ann Thorac Cardiovasc Surg"},{"key":"BF03022797_CR22","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.athoracsur.2004.02.088","volume":"78","author":"S Karthik","year":"2004","unstructured":"Karthik S, Grayson AD, McCarron EE, Pullan DM, Desmond MJ. Reexploration for bleeding after coronary artery bypass surgery: risk factors, outcomes, and the effect of time delay. Ann Thorac Surg 2004; 78:527\u201334.","journal-title":"Ann Thorac Surg"},{"key":"BF03022797_CR23","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1001\/archsurg.133.4.442","volume":"133","author":"LJ Dacey","year":"1998","unstructured":"Dacey LJ, Munoz JJ, Baribeau YR, et al. Reexploration for hemorrhage following coronary artery bypass grafting. Incidence and risk factors. Northern New England Cardiovascular Disease Study Group. Arch Surg 1998; 133:442\u20137.","journal-title":"Arch Surg"},{"key":"BF03022797_CR24","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1097\/00003246-199712000-00018","volume":"25","author":"T Ryan","year":"1997","unstructured":"Ryan T, Mc Carthy JF, Rady MY, et al. Early bloodstream infection after cardiopulmonary bypass: frequency rate, risk factors, and implications. Crit Care Med 1997; 25:2009\u201314.","journal-title":"Crit Care Med"},{"key":"BF03022797_CR25","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/0003-4975(94)00995-3","volume":"59","author":"MJ Unsworth-White","year":"1995","unstructured":"Unsworth-White MJ, Herriot A, Valencia O, et al. Resternotomy for bleeding after cardiac operation: a marker for increased morbidity and mortality. Ann Thorac Surg 1995; 59:664\u20137.","journal-title":"Ann Thorac Surg"},{"key":"BF03022797_CR26","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1378\/chest.119.5.1461","volume":"119","author":"SR Leal-Noval","year":"2001","unstructured":"Leal-Noval SR, Rincon-Ferrari MD, Garcia-Curiel A, et al. Transfusion of blood components and postoperative infection in patients undergoing cardiac surgery. Chest 2001; 119:1461\u20138.","journal-title":"Chest"},{"key":"BF03022797_CR27","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1053\/j.semtcvs.2004.01.009","volume":"16","author":"TD Crabtree","year":"2004","unstructured":"Crabtree TD, Codd JE, Fraser VJ, Bailey MS, Olsen MA, Damiano RJ Jr. Multivariate analysis of risk factors for deep and superficial sternal infection after coronary artery bypass grafting at a tertiary care medical center. Semin Thorac Cardiovasc Surg 2004; 16:53\u201361.","journal-title":"Semin Thorac Cardiovasc Surg"},{"key":"BF03022797_CR28","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1161\/01.CIR.97.6.562","volume":"97","author":"LM Watering van de","year":"1998","unstructured":"van de Watering LM, Hermans J, Houbiers JG, et al. Beneficial effects of leukocyte depletion of transfused blood on postoperative complications in patients undergoing cardiac surgery. A randomized clinical trial. Circulation 1998; 97:562\u20138.","journal-title":"Circulation"},{"key":"BF03022797_CR29","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1111\/j.0041-1132.2003.00633.x","volume":"43","author":"NS Key","year":"2003","unstructured":"Key NS. Recombinant FVIIa for intractable hemorrhage: more questions than answers (Editorial). Transfusion 2003; 43:1649\u201351.","journal-title":"Transfusion"},{"issue":"Suppl 1","key":"BF03022797_CR30","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1053\/j.seminhematol.2003.11.019","volume":"41","author":"HR Roberts","year":"2004","unstructured":"Roberts HR, Monroe DM III, Hoffman M. Safety profile of recombinant factor VIIa. Semin Hematol 2004; 41(Suppl 1):101\u20138.","journal-title":"Semin Hematol"},{"key":"BF03022797_CR31","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1093\/bja\/aei244","volume":"95","author":"P Diprose","year":"2005","unstructured":"Diprose P, Herbertson MJ, O\u2019Shaughnessy D, Gill RS. Activated recombinant factor VII after cardiopulmonary bypass reduces allogeneic transfusion in complex non-coronary cardiac surgery: randomized double-blind placebo-controlled pilot study. Br J Anaesth 2005; 95:596\u2013602.","journal-title":"Br J Anaesth"}],"container-title":["Canadian Journal of Anesthesia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03022797.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03022797\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03022797","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,17]],"date-time":"2020-05-17T22:00:10Z","timestamp":1589752810000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03022797"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,8]]},"references-count":31,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2006,8]]}},"alternative-id":["BF03022797"],"URL":"https:\/\/doi.org\/10.1007\/bf03022797","relation":{},"ISSN":["0832-610X","1496-8975"],"issn-type":[{"value":"0832-610X","type":"print"},{"value":"1496-8975","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,8]]}}}